Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities      
Net income $ 17,431 $ 52,032 $ 65,306
Adjustments to reconcile net income to net cash provided by operating activities      
Depreciation and amortization 14,120 16,379 24,400
Net amortization of investments 8,671 6,854 6,091
Additions to the allowance for doubtful receivables 1,601 16,121 14,819
Deferred tax benefit (8,326) (5,070) (21,806)
Net realized investment gain on sale of securities (17,379) (18,941) (18,231)
Interest credited to policyholder deposits 3,794 5,690 3,510
Share-based compensation 2,463 8,290 2,371
(Increase) decrease in assets      
Premium and other receivables, net (5,320) 6,399 (45,046)
Deferred policy acquisition costs and value of business acquired (7,286) (6,548) (6,811)
Deferred taxes (4,799) 3,616 1,954
Other assets (9,009) (2,630) 8,630
(Decrease) increase in liabilities      
Claim liabilities (3,822) 101,679 (30,335)
Liability for future policy benefits 31,702 18,146 23,930
Unearned premiums (950) (2,396) (4,706)
Liability to FEHBP 7,675 11,029 7,518
Accounts payable and accrued liabilities (24,095) 18,444 6,397
Net cash provided by operating activities 6,471 229,094 37,991
Securities available for sale      
Fixed maturities sold 400,848 355,045 235,282
Fixed maturities matured 56,988 67,615 31,329
Equity securities sold 109,049 100,152 113,942
Securities held to maturity      
Fixed maturities matured 1,538 640 4,127
Other investments 0 0 8,925
Securities available for sale      
Fixed maturities (482,252) (469,198) (288,507)
Equity securities (163,119) (92,844) (69,101)
Securities held to maturity      
Fixed maturities (1,445) (624) (935)
Other investments (2,493) (2,427) (483)
Net disbursements for policy loans (663) (641) (555)
Net capital expenditures (4,750) (9,094) (4,783)
Net cash (used in) provided by investing activities (86,299) (51,376) 29,241
Cash flows from financing activities      
Repurchase and retirement of common stock (21,371) (48,287) (11,337)
Change in outstanding checks in excess of bank balances 12,250 (1,786) (4,858)
Repayments of long-term borrowings (1,742) (37,640) (14,835)
Proceeds from policyholder deposits 18,224 16,563 9,551
Surrenders of policyholder deposits (21,923) (18,787) (10,072)
Net cash used in financing activities (14,562) (89,937) (31,551)
Net (decrease) increase in cash and cash equivalents (94,390) 87,781 35,681
Cash and cash equivalents      
Beginning of year 197,818 110,037 74,356
End of year $ 103,428 $ 197,818 $ 110,037